<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03165825</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #170187</org_study_id>
    <nct_id>NCT03165825</nct_id>
  </id_info>
  <brief_title>Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection</brief_title>
  <official_title>Pragmatic Randomized Prospective Study of Cervical Interlaminar Epidural Injection of Particulate Steroid and Cervical Transforaminal Epidural Injection of Non-particulate Steroid in Patients With Cervical Radicular Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      compare cervical interlaminar epidural injection of betamethasone (9mg) and cervical
      transforaminal epidural injection of dexamethasone (15 mg) for cervical radicular pain
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare one route of epidural steroid injection (interlaminar) using a
      particulate steroid to another route of epidural steroid injection (transforaminal) using a
      different non-particulate steroid dexamethasone. Repeat injections may be allowed.

      All injections will be done with image guidance. Patients will be evaluated for improvements
      in pain and function.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>12 months</time_frame>
    <description>Numeric rating pain score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Cervical Radiculopathy</condition>
  <arm_group>
    <arm_group_label>Tranforaminal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive cervical epidural injection via a transforaminal route with dexamethasone steroid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interlaminar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive cervical epidural injection via an interlaminar route with betamethasone steroid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transforaminal Epidural Steroid Injection with Dexamethasone</intervention_name>
    <description>Transforaminal Epidural Steroid Injection with Dexamethasone</description>
    <arm_group_label>Tranforaminal</arm_group_label>
    <other_name>Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Interlaminar Epidural Steroid Injection with Betamethasone</intervention_name>
    <description>Interlaminar Epidural Steroid Injection with Betamethasone</description>
    <arm_group_label>Interlaminar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - aged &gt;18, capable of understanding and providing consent in English, capable of
             complying with the outcome instruments used, capable of attending all planned follow
             up visits

          -  unilateral cervical radicular pain as defined by arm pain or shoulder girdle
             pain/periscapular pain with or without neck pain of at least 2 weeks.

          -  7 day average of numeric pain rating score (NPRS) for arm pain or shoulder
             girdle/periscapular pain of at least 5/10 at baseline evaluation

          -  MRI (or CT if MRI not available) shows one or two level cervical disc herniation(s) or
             disc osteophyte complex(es) between levels C4-T1, corresponding in location with
             unilateral radicular pain, with or without neurological deficits. MRI or CT may show
             degenerative changes at other levels.

          -  Patient consents to treatment with epidural injection in a shared decision-making
             process with the treating physician.

          -  Pain duration of at least 2 weeks or more.

        Exclusion Criteria:

          -  - Neck pain is greater than arm pain or shoulder girdle/periscapular pain based on 7
             day average NPRS

          -  Those receiving remuneration for their pain treatment (e.g., disability, worker's
             compensation).

          -  Those involved in active litigation relevant to their pain.

          -  Those unable to read English and complete the assessment instruments.

          -  Those unable to attend follow up appointments

          -  The patient is incarcerated.

          -  Spondylolisthesis at the involved or adjacent segments.

          -  History of prior cervical surgery

          -  Progressive motor deficit, and/or clinical signs of myelopathy.

          -  Prior cervical epidural steroid injections.

          -  Prior epidural steroid injection within the prior 12 months in any location within the
             spine.

          -  Possible pregnancy or other reason that precludes the use of fluoroscopy.

          -  Allergy to contrast media or local anesthetics.

          -  BMI&gt;35.

          -  Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis,
             lupus).

          -  Active infection or treatment of infection with antibiotics within the past 7 days.

          -  Medical conditions causing significant functional disability (e.g., stroke, COPD)

          -  Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).

          -  Addictive behavior, severe clinical depression, or psychotic features.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Byron Schneider</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Byron Schneider</last_name>
    <phone>6153220738</phone>
    <email>byron.j.schneider@vanderbilt.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Byron Schneider</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2017</study_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Byron Schneider</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

